FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391633002: Alemtuzumab 30mg/3mL infusion concentrate (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1465813010 Alemtuzumab 30mg/3mL infusion concentrate (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    1485633019 Alemtuzumab 30mg/3mL infusion concentrate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Alemtuzumab 30mg/3mL infusion concentrate Is a Product containing alemtuzumab (medicinal product) false Inferred relationship Some
    Alemtuzumab 30mg/3mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Alemtuzumab false Inferred relationship Some
    Alemtuzumab 30mg/3mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some
    Alemtuzumab 30mg/3mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Biological agent false Inferred relationship Some
    Alemtuzumab 30mg/3mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Monoclonal antibody false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start